Yposkesi, an SK pharmteco company
Created in 2016
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
377 9,732Activities
Technologies
Entity types
Location
20 Rue Henri Auguste Desbruères, 91000 Évry-Courcouronnes, France
Évry-Courcouronnes
France
Employees
Scale: 51-200
Estimated: 174
SIREN
815409503Engaged corporates
18
4 15Added in Motherbase
5 years, 2 months ago
deeptech Value proposition
Partnering to bring your cell and gene therapies to life!
***This page has moved and is no longer active. Please follow us @SK pharmteco for all company news and updates.***
Yposkesi, an SK pharmteco company, is one of Europe’s largest Contract Development and Manufacturing Organizations (CDMO) for gene therapy viral vector manufacturing.
As a trusted partner for biotech and pharmaceutical companies seeking to advance clinical trials and commercialize new Advanced Therapy Medicinal Products (ATMPs), Yposkesi offers a full range of services in lentiviral vectors and AAV (Adeno-Associated Virus) cGMP manufacturing. Within its current 50,000 ft2 (approx. 5,000 m2) facility, Yposkesi operates multiple manufacturing suites for bulk drug substances (up to 1,000 L) and fill and finish to support the growing demand for late-phase projects. In 2023, Yposkesi will bring online additional capacity by increasing its global footprint to 100,000 ft2 (approx. 10,000 m2) with a second large-scale facility designed for EMA and FDA compliance.
Yposkesi’s investment in innovation ensures that its bioprocessing platforms deliver high-quality gene-modified cell therapies and in vivo gene therapy projects.
Yposkesi’s staff of ~200 employees is located on the Genopole Campus in Corbeil-Essonnes (South of Paris), France.
• Bioprocess development (USP & DSP), • GMP manufacturing of clinical and commercial batches, • Analytical development, assays qualification & validation, • Fill & Finish, and • Regulatory supportOriginal language
Partnering to bring your cell and gene therapies to life!
***This page has moved and is no longer active. Please follow us @SK pharmteco for all company news and updates.***
Yposkesi, an SK pharmteco company, is one of Europe’s largest Contract Development and Manufacturing Organizations (CDMO) for gene therapy viral vector manufacturing.
As a trusted partner for biotech and pharmaceutical companies seeking to advance clinical trials and commercialize new Advanced Therapy Medicinal Products (ATMPs), Yposkesi offers a full range of services in lentiviral vectors and AAV (Adeno-Associated Virus) cGMP manufacturing. Within its current 50,000 ft2 (approx. 5,000 m2) facility, Yposkesi operates multiple manufacturing suites for bulk drug substances (up to 1,000 L) and fill and finish to support the growing demand for late-phase projects. In 2023, Yposkesi will bring online additional capacity by increasing its global footprint to 100,000 ft2 (approx. 10,000 m2) with a second large-scale facility designed for EMA and FDA compliance.
Yposkesi’s investment in innovation ensures that its bioprocessing platforms deliver high-quality gene-modified cell therapies and in vivo gene therapy projects.
Yposkesi’s staff of ~200 employees is located on the Genopole Campus in Corbeil-Essonnes (South of Paris), France.
Yposkesi | European CDMO in gene therapy & viral vector manufacturing - Yposkesi
Yposkesi is a French-based CDMO offering bioprocess development and cGMP manufacturing services for AAV and lentiviral vector production.
https://www.yposkesi.com/?utm_source=linkedin%20company%20page%20description&utm_medium=social&utm_campaign=linkedin%20company%20page%20description
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 | IMT Mines Albi | Other 26 Jan 2023 | | |
 Bristol Myers Squibb Pharmaceutical, Pharmaceutical Manufacturing | Bristol Myers Squibb Pharmaceutical, Pharmaceutical Manufacturing | Other 9 Aug 2023 | | |
 Eurofins Scientifique Biotechnology, Biotechnology Research | Eurofins Scientifique Biotechnology, Biotechnology Research | Other 19 May 2023 | | |
 Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Other 19 May 2023 | | |
 La Tribune Media, Newspapers | La Tribune Media, Newspapers | Other 22 Aug 2018 | | |
 VINCI Construction Construction, Real Estate | VINCI Construction Construction, Real Estate | Other 30 Nov 2022 | | |
 AbbVie Pharmaceutical, Pharmaceutical Manufacturing | AbbVie Pharmaceutical, Pharmaceutical Manufacturing | Other 31 Oct 2022 | | |
 Merck Group Pharmaceutical, Biotechnology, Pharmaceutical Manufacturing | Merck Group Pharmaceutical, Biotechnology, Pharmaceutical Manufacturing | Other 20 Jan 2022 | | |
 Pfizer Pharmaceutical, Pharmaceutical Manufacturing | Pfizer Pharmaceutical, Pharmaceutical Manufacturing | Other 31 Oct 2022 | | |
 Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Not capitalistic Partnership Event 18 Feb 2019 5 Jul 2024 | | |